Land: Australien
Sprog: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
mupirocin, Quantity: 22 mg/g
GlaxoSmithKline Australia Pty Ltd
Mupirocin
Ointment
Excipient Ingredients: macrogol 3350; macrogol 400
Topical
1g, 15g, 15g(E), 5g, 2g, 30g
Medicine Registered
(S4) Prescription Only Medicine, Not scheduled. Not considered by committee
BACRTOBAN (mupirocin) ointment is indicated for the topical treatment of mild impetigo.
Visual Identification: A white to off-white ointment; Container Type: Tube; Container Material: Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1991-08-14
BACTROBAN ® OINTMENT _Mupirocin (2%w/w)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? Please read this leaflet carefully before you use BACTROBAN ointment. This leaflet answers some common questions about BACTROBAN ointment. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the expected benefits of you using BACTROBAN ointment against the risks this medicine could have for you. If you are helping someone else to use BACTROBAN ointment, read this leaflet before applying the first application. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT BACTROBAN OINTMENT IS USED FOR BACTROBAN ointment contains mupirocin (2% w/w) as the active ingredient. Mupirocin belongs to a group of medicines called antibiotics. Antibiotics work by killing bacteria which can cause infection. BACTROBAN ointment is used for the treatment of mild impetigo (school sores). BACTROBAN ointment is for use on your skin only. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed BACTROBAN ointment for another reason. BACTROBAN ointment is not addictive. BEFORE YOU USE BACTROBAN OINTMENT _WHEN YOU MUST NOT USE IT_ YOU MUST NOT USE BACTROBAN OINTMENT IF YOU HAVE AN ALLERGY TO: • any medicine containing mupirocin • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin DO NOT USE BACTROBAN OINTMENT AFTER THE EXPIRY DATE PRINTED ON THE PACK, OR THE OINTMENT SHOWS VISIBLE SIGNS OF DETERIORATION, OR IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. If it has expired or is damaged, return it to your pharma Læs hele dokumentet
1 AUSTRALIAN PRODUCT INFORMATION BACTROBAN (MUPIROCIN CALCIUM) CREAM AND OINTMENT 1 NAME OF THE MEDICINE Mupirocin calcium. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION BACTROBAN cream and BACTROBAN ointment contain mupirocin calcium 2% w/w equivalent to 20 mg mupirocin as the active ingredient. LIST OF EXCIPIENTS WITH KNOWN EFFECT For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM Cream or ointment. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS BACTROBAN (mupirocin) cream is indicated for the topical treatment of secondarily infected traumatic skin lesions such as small lacerations, sutured wounds or abrasions. BACTROBAN (mupirocin) ointment is indicated for the topical treatment of mild impetigo. 4.2 DOSE AND METHOD OF ADMINISTRATION For Dermatologic Use. A small amount of BACTROBAN should be applied to the affected area three times daily. The area treated may be covered with a gauze dressing if desired. Usually treatment should not continue for more than 10 days. RENAL IMPAIRMENT (BACTROBAN OINTMENT) Refer to Section 4.4 SPECIAL WARNINGS AND PRECAUTIONS. 4.3 CONTRAINDICATIONS BACTROBAN cream and BACTROBAN ointment are contraindicated in patients who have demonstrated hypersensitivity to mupirocin calcium or any components of the formulations. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If a reaction suggesting sensitivity or chemical irritation should occur with the use of BACTROBAN, treatment should be discontinued, the product should be wiped off and appropriate alternative therapy for the infection instituted. 2 BACTROBAN is not suitable for ophthalmic use, intranasal use or application to other mucosal surfaces. Avoid contact with eyes. If contaminated, the eyes should be thoroughly irrigated with water until the residues have been removed. BACTROBAN is not suitable for application to the site of cannulation or for use in conjunction with cannulae. Polyethylene glycol (macrogol) can be absorbed from open wounds and damaged skin and is excreted by the kidneys. In Læs hele dokumentet